Hangxiang Wang

29PUBLICATIONS
16CO-AUTHORS
Medical devicesNanomaterialsTumour immunologyInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Dec 03, 2024
Correction to "Enhancing the Efficacy and Safety of Doxorubicin against Hepatocellular Carcinoma through a Modular Assembly Approach: The Combination of Polymeric Prodrug Design, Nanoparticle Encapsulation, and Cancer Cell-Specific Drug Targeting".

Li Xu, Shengjun Xu, Hangxiang Wang

|Nov 04, 2024
Hybrid Homodimeric Prodrug Nanoassemblies for Low-Toxicity and Synergistic Chemophotodynamic Therapy of Melanoma.

Peirong Xu, Fanchao Meng, Jianqin Wan

|Sep 03, 2024
Mitochondrial rewiring with small-molecule drug-free nanoassemblies unleashes anticancer immunity.

Lulu Ren, Jianqin Wan, Xiaoyan Li

|Jul 11, 2024
Ionizable STING-Activating Nanoadjuvants Enhance Tumor Immunogenicity and Potentiate Immunotherapy Efficacy in Solid Tumors.

Shiyun Xian, Xiaona Chen, Sihang Ren

|Jul 09, 2024
STING-Activating Small Molecular Therapeutics for Cancer Immunotherapy.

Chuhan Huang, Tianrui Tong, Lulu Ren

|May 29, 2024
Syringeable Near-Infrared Light-Activated In Situ Immunogenic Hydrogel Boosts the Cancer-Immunity Cycle to Enhance Anticancer Immunity.

Yang Fu, Xiaoxiao Zhu, Lulu Ren

Pageof 5

Frequent Collaborators

2 joint publications

Li Xu

2 joint publications

Chao Chen

2 joint publications

Jianqing Gao

2 joint publications

Kanyi Pu